MUMBAI-The upcoming streaming series ‘The Tatas’ is set to tell the story of one of India’s oldest business families and its role in shaping the nation’s industrial and social development. Envisioned ...

After the success of Made in India: A Titan Story, T-Series Films and Almighty Motion Picture have once again teamed up for The Tatas, a multi-season drama adapting Girish Kuber's book The Tatas: How ...

Karan Vyas who has served as a writer on Made in India: A Titan Story, will adapt Kuber's novel. Speaking about the series, Karan said, "The deeper I went into the archives of the Tata family, the ...

Following their successful partnership on the film Made in India: A Titan Story, T-Series Films and Almighty Motion Pictures have now come together to create an even more ambitious project. The two ...

India’s T-Series Films and Almighty Motion Picture, the team behind hit Amazon MX Player series “Made in India: A Titan Story,” are reuniting for “The Tatas,” a multi-season drama adapting Girish ...

Nagpur: Union minister Nitin Gadkari on Sunday said Tata Motors has expressed interest in establishing a hydrogen-powered bus project in Nagpur, a move that could accelerate the city's transition ...

The 6th annual Tee Off for Tatas Golf Tournament, presented by Street Volkswagen, was a tremendous success, bringing together golfers, sponsors and volunteers for a day of friendly competition, ...

THE TRIBUNE, India’s oldest, daily English-language newspaper, was first published on February 2, 1881, in Lahore (now in Pakistan), and save for 40 days in the immediate aftermath of Partition, has ...

LOS ANGELES, CA – Tata Communications has acquired a 51 per cent stake in the AI-native enterprise SaaS firm Commotion Inc., headquartered here, in a strategic move to bolster its AI-led customer ...

There is a simple discount patient access scheme for serplulimab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Evidence-based recommendations on cemiplimab (Libtayo) with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer in adults. This guidance updates and replaces NICE technology ...